OX40 agonists for cancer treatment: a patent review.
Expert Opin Ther Pat. 2021 Jan;31(1):81-90. doi: 10.1080/13543776.2021.1825688. Epub 2020 Oct 6.
Expert Opin Ther Pat. 2021.
PMID: 32945223